« Nasdaq unveils 'Cubes' direct-buy | Main | Sumitomo rolls out Calypso »

March 16, 2006

FDA panel OKs risky

FDA panel OKs risky MS drug
CNN - WASHINGTON (AP) -- A promising drug for multiple sclerosis should be returned to the market despite questions about a rare brain disease, scientific advisers told the government Wednesday -- even as they continued to grapple with just who should be

Wolves opt to stand pat, but aren't sitting around
Minneapolis Star Tribune - As practice wound down Thursday afternoon it became pretty clear that Timberwolves coach Dwane Casey had the same team and the same challenge: Take a team altered by a trade a month ago and try to get it to the point where it's still contending for a

BioMarin, Serono Metabolic Drug Effective
MSN MoneyCentral - NEW YORK (AP) - Biopharmaceuticals company BioMarin Pharmaceutical Inc. and Serono SA said on Wednesday the results of its late-stage study of Phenoptin were positive, sending up shares of both in after-hours trading. The results of the Phase 3 study

Dow closes up 75, Nasdaq finishes up 29
Seattle Post Intelligencer - NEW YORK -- A plunge in Treasury bond yields propelled stocks sharply higher Tuesday as investors grew optimistic that the Federal Reserve's streak of interest rate hikes will soon end. Record revenues and a jump in profits at Goldman Sachs Group Inc

Apple is going to have a very good year
Marketwatch - Tomorrow's Hot Stock Pick Free reports, picks, and tips on potentially huge winners. Penny stocks, undervalued, and undiscovered situations. Unique ideas to make money now. http://www.RocketStockPicks.com Buy Stocks Online at Scottrade $7 stock

Posted by auctionbullet at March 16, 2006 07:27 AM